Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

NCT02114658 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer